Does the NAFCS Score accurately distinguish patients with FCS from MCS?
The NAFCS Score provides a simple, highly specific clinical tool to identify familial chylomicronemia syndrome, potentially reducing the immediate need for genetic testing.
Given its simplicity and high specificity for distinguishing patients with FCS from MCS, the NAFCS Score could be used in lieu of - or while awaiting - genetic testing to optimize treatment.
Hegele et al. (Wed,) studied this question.